Results 31 to 40 of about 15,503 (243)

Alopecia areata

open access: yesDer Hautarzt, 2013
The epidemiology of alopecia areata as well as murine models of this disease and genome-wide association studies support the concept of alopecia areata as an autoimmune disease. In addition, the genome-wide association studies have led to the identification of new potential therapeutic targets such as CTLA4; these results have already led to the ...
V, von Felbert, H F, Merk
openaire   +4 more sources

Alopecia Areata and it’s Association with Thyroid Dysfunction

open access: yesJournal of Nobel Medical College, 2021
Background: Out of many cause of non-scarring alopecia, alopecia areata is one the cause of non-scarring alopecia. Most study till now has shown autoimmunity to be pathogenesis of alopecia areata and has found to be frequently associated with abnormal ...
Anjan Rai   +3 more
doaj   +1 more source

Electrocardiogram Findings in Patients with Alopecia Areata [PDF]

open access: yes, 2021
IntroductionWhile autoimmune comorbidities are common in alopecia areata, little is known about comorbid cardiovascular disease. The purpose of this study was to evaluate the incidence of bradyarrhythmia in patients with alopecia areata ...
Lampert, Rachel   +7 more
core   +1 more source

Alopecia areata incognita [PDF]

open access: yesClinics, 2011
Alopecia areata incognita, also known as diffuse alopeciaareata, is a rare form of alopecia areata described pre-dominantly in young women. In cases of alopecia areataincognita, the typical patchy distribution of hair loss inclassical alopecia areata is absent, but abrupt and intensehair loss is characteristic.
Molina, Luciana   +3 more
openaire   +6 more sources

Adiponectin as a novel biomarker of disease severity in alopecia areata

open access: yesScientific Reports, 2021
The frequent coexistence of obesity and metabolic syndrome in patients with alopecia areata may indicate the common pathogenetic pathway in these conditions with an important role of adipokines.
Anna Stochmal   +6 more
doaj   +1 more source

Tofacitinib in a Recalcitrant Case of Alopecia Areata

open access: yesGAIMS Journal of Medical Sciences, 2022
Alopecia areata (AA) is a non-cicatricial alopecia that is postulated to be a hair-specific autoimmune disease, with genetic factors playing a role in disease susceptibility and severity.
Mansi Pithadia   +3 more
doaj   +1 more source

Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis

open access: yesActa Dermato-Venereologica, 2023
Alopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the ...
Nicolae Done   +6 more
doaj   +1 more source

Alopecia areata: a new treatment plan

open access: yes, 2011
Adel AlsantaliDepartment of Dermatology, King Fahd Armed Forces Hospital, Jeddah, Saudi ArabiaAbstract: Many therapeutic modalities have been used to treat alopecia areata, with variable efficacy and safety profiles.
Alsantali A, Adel Alsantali
core   +1 more source

Cognitive-behavioural psychotherapy and alopecia areata

open access: yes, 2017
Alopecia areata (also known as spot baldness) is a disease with multifactorial aetiology, including genetic, hormonal, autoimmune and  psychological factors as well as nervous system disorders.
Marta Kuty-Pachecka
core   +1 more source

Effectiveness and Predictive Factors of Response to Tofacitinib Therapy in 125 Patients with Alopecia Areata: A Single-centre Real-world Retrospective Study

open access: yesActa Dermato-Venereologica, 2023
Alopecia areata is an autoimmune disorder that greatly impacts patients’ quality of life, and its management remains challenging. Tofacitinib is the first Janus kinase inhibitor to be approved for clinical use and is the most extensively studied. Several
Jundong Huang   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy